Gene expression analysis identifies a genetic signature potentially associated with response to α-IFN in chronic phase CML patients-Reference-Cited by-同舟云学术

Gene expression analysis identifies a genetic signature potentially associated with response to α-IFN in chronic phase CML patients

Published:2007-07 Issue:7 Volume:31 Page:931-938
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Hagberg Anette,Olsson-Strömberg Ulla,Wickenberg-Bolin Ulrika,Göransson Hanna,Isaksson Anders,Bengtsson Mats,Höglund Martin,Simonsson Bengt,Barbany Gisela

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference37 articles.

1. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukaemia. The German CML Study Group;Hehlmann;Blood,1994

2. A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia;Baccarani;Blood,2002

3. Analysis and validation of prognostic factors for CML. German CML Study Group;Hasford;Bone Marrow Transplant,1996

4. Complete molecular remission in chronic myelogenous leukemia after imatinib therapy;Barbany;N Engl J Med,2002

5. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia;Hughes;N Engl J Med,2003

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. α-Defensin 1-3 And α-Defensin 4 as Predictive Markers of Imatinib Resistance and Relapse in CML Patients;Disease Markers;2011

2. The impact of gene profiling in chronic myeloid leukaemia;Best Practice & Research Clinical Haematology;2009-06

3. Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia;Leukemia & Lymphoma;2008-01

4. Whole blood;Microarrays in Inflammation;2008